GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Asahi Kasei Corp (TSE:3407) » Definitions » Change In Payables And Accrued Expense

Asahi Kasei (TSE:3407) Change In Payables And Accrued Expense : 円0 Mil (TTM As of Mar. 2024)


View and export this data going back to 1949. Start your Free Trial

What is Asahi Kasei Change In Payables And Accrued Expense?

Asahi Kasei's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2024 was 円0 Mil. It means Asahi Kasei's Accounts Payable & Accrued Expense stayed the same from Dec. 2023 to Mar. 2024 .

Asahi Kasei's Change In Payables And Accrued Expense for the fiscal year that ended in Mar. 2024 was 円0 Mil. It means Asahi Kasei's Accounts Payable & Accrued Expense stayed the same from Mar. 2023 to Mar. 2024 .


Asahi Kasei Change In Payables And Accrued Expense Historical Data

The historical data trend for Asahi Kasei's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asahi Kasei Change In Payables And Accrued Expense Chart

Asahi Kasei Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Change In Payables And Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Asahi Kasei Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Payables And Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Asahi Kasei Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Asahi Kasei Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Asahi Kasei's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Asahi Kasei (TSE:3407) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Asahi Kasei Corp (TSE:3407) » Definitions » Change In Payables And Accrued Expense
Traded in Other Exchanges
Address
1-105 Kanda Jinbocho, Chiyoda-ku, Tokyo, JPN, 101-8101
Asahi Kasei Corp is a holding company that, through its subsidiaries, sells a variety of products and services. The firm is organized into four segments based on product or service. The chemicals and fibers segment, which generates the most revenue of any segment, sells ammonia-based products including plastic compounds and cellulose fiber. The homes and construction segment builds residential houses and sells thermal insulation. The electronics segment sells components for mobile phones including electronic compasses and lithium-ion battery separators. The healthcare segment sells medical devices including blood purification, blood transfusion, and bioprocess products. The majority of revenue comes from Japan.

Asahi Kasei (TSE:3407) Headlines

No Headlines